atrial fibrillation, non valvular, stroke, ischemic, cerebral infarction, embolic, older patients
DISEASE INTERVENTION COMPARISON RESULTS
Circulation. 2014 Jul 8;130(2):138-46 Randomized Controlled Trial, Multicenter Study
IN atrial fibrillation, non valvular, stroke, ischemic, cerebral infarction, embolic, older patients The Use of
anticoagulants, oral factor Xa inhibitors, rivaroxaban
As Treatment, Chronic
Is equal Than
vitamine K antagonists, warfarin
To modify, in patients > 75 years, stroke (2.29% rivaroxaban VS 2.85% warfarin per 100 patient-years) or major bleeding (4.86% rivaroxaban versus 4.40% warfarin per 100 patient-years). Older patients had more strokes and major bleedings than young ones